Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

223
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
223
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

522
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
522
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

380
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
380
Clinical Trials01:16

Clinical Trials

9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

583
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
583
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

54
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

American journal of nephrology·2026
Same author

Examining the Direct and Indirect Effects of Socioeconomic Status on Colorectal Cancer Using Structural Equation Modeling.

Cancer investigation·2025
Same author

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non<b>-</b>Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO<sub>2</sub>TECT Randomized Clinical Trial of ESA-Treated Patients.

Kidney medicine·2023
Same author

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO<sub>2</sub>TECT Randomized Clinical Trial of ESA-Naïve Patients.

Kidney medicine·2023
Same author

Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival.

Cancer biology & medicine·2023
Same author

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023

Related Experiment Video

Updated: Nov 8, 2025

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.6K

Randomized Controlled Trials 4: Planning, Analysis, and Interpretation of Quality-of-Life Studies.

Robert N Foley1, Patrick S Parfrey2

  • 1USRDS Co-ordinating Center, Minneapolis, MN, USA.

Methods in Molecular Biology (Clifton, N.J.)
|April 19, 2021
PubMed
Summary

Quality-of-life (QoL) outcomes are crucial in clinical trials. Addressing missing data and defining minimal important differences are key for valid QoL assessments and informed treatment decisions.

Keywords:
AssessmentMeasurement scalesMinimal clinically important differenceMissing dataPatient reported outcomeQuality of lifeQuality-adjusted survival

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

860
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
11:21

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data

Published on: July 27, 2018

8.4K

Related Experiment Videos

Last Updated: Nov 8, 2025

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

860
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
11:21

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data

Published on: July 27, 2018

8.4K

Area of Science:

  • Clinical Trials Methodology
  • Health Outcomes Research

Background:

  • Quality-of-life (QoL) is a critical endpoint in clinical trials.
  • QoL measurement tools vary, necessitating careful selection and outcome prespecification.
  • Missing data can compromise the validity of QoL assessments.

Purpose of the Study:

  • To highlight the importance of QoL outcomes in randomized controlled trials.
  • To discuss strategies for handling missing QoL data.
  • To emphasize the need for robust methods in defining minimal clinically important differences (MCIDs) in QoL.

Main Methods:

  • Review of QoL measurement considerations in clinical trials.
  • Discussion of statistical approaches for managing missing data.
  • Examination of methods for determining MCIDs.

Main Results:

  • Prespecifying QoL outcomes can mitigate concerns from multiple comparisons.
  • Effective strategies for accounting for missing data are essential for trial validity.
  • Current methods for defining MCIDs in QoL are often inadequate.

Conclusions:

  • Robust handling of missing QoL data is necessary for reliable trial results.
  • Integrated measures of survival and QoL aid treatment decision-making.
  • Improved methodologies are needed for defining clinically meaningful QoL score changes.